1. Beaulieu P, Babin D, Hemmerling T. The pharmacodynamics of ropivacaine and bupivicaine in combined sciatic and femoral nerve blocks for total knee arthroplasty. Anesth Analg. 2006;103:768-774.
2. McGlade DP, Kalpokas MV, Mooney PH, et al. A comparison of
0.5% ropivacaine and 0.5% bupivacaine for axillary brachial plexus
anaesthesia. Anaesth Intensive Care. 1998;26:515-520.
Pain After Laparoscopic Cholecystectomy. Surg Today, 2007; 37:396-400.
3. Scott DB, Lee A, Fagan D, et al. Acute toxicity of ropivacaine compared with that of bupivacaine. Anesth Analg. 1989;69:563-569.
4. Knudsen K, Beckman Suurküla M, Blomberg S, et al. Central nervous and cardiovascular effects of i.v. infusions of ropivacaine, bupivacaine and placebo in volunteers. Br J Anaesth. 1997;78:507-514.
5. Brooks K, Pasero C, Hubbard L, Coghlan RH. The risk of infection associated with epidural analgesia. Infect Control Hosp Epidemiol. 1995 Dec;16(12):725-8.
6. NHS. Clinical Guideline for the Care of Epidural Infusions (Adult). Accessible via:
www.rcht.nhs.uk/GET/d101591487. AWMF. S1 Leitlinie - Hygieneempfehlungen für die Regionalanästhesie. [German guideline: Recommendations for hygiene in regional anaesthesia].Nov 2014. Accessible via:
http://www.awmf.org/uploads/tx_szleitlinien/001014l_S1_Hygieneempfehlungen__RegionalAnästhesie_2014-11.pdf